Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
33.62
-1.74 (-4.92%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Revolution Medicines Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2017
Net Income
-600.09-436.37-248.71-187.09-108.16
Upgrade
Depreciation & Amortization
10.728.218.566.235.45
Upgrade
Other Amortization
1.11.11.11.11.1
Upgrade
Loss (Gain) From Sale of Assets
0.120.050.020.12-
Upgrade
Loss (Gain) From Sale of Investments
-44.57-22.21-3.083.010.97
Upgrade
Stock-Based Compensation
79.261.7731.220.728.89
Upgrade
Other Operating Activities
-4.320.12---
Upgrade
Change in Accounts Receivable
1.253.421.260.462.34
Upgrade
Change in Accounts Payable
-6.4732.477.292.240.31
Upgrade
Change in Unearned Revenue
--4.46-14.47-1.66-11.26
Upgrade
Change in Other Net Operating Assets
6.389.23-7.147.680.68
Upgrade
Operating Cash Flow
-557.44-350.57-224.4-147.18-100.06
Upgrade
Capital Expenditures
-10.31-7.73-10.82-6.53-2.93
Upgrade
Investment in Securities
-544.09-334.87-13.3-135.59-231.3
Upgrade
Investing Cash Flow
-554.39-342.6-24.12-142.12-234.23
Upgrade
Issuance of Common Stock
863.71392.39301.39294.6422.78
Upgrade
Repurchase of Common Stock
--4.03---
Upgrade
Other Financing Activities
95.71840.830.04-0.42-
Upgrade
Financing Cash Flow
959.411,229301.43294.18422.78
Upgrade
Net Cash Flow
-152.42536.0352.924.8888.48
Upgrade
Free Cash Flow
-567.74-358.3-235.22-153.71-103
Upgrade
Free Cash Flow Margin
--3094.14%-664.83%-522.99%-239.62%
Upgrade
Free Cash Flow Per Share
-3.38-3.17-2.92-2.11-1.88
Upgrade
Levered Free Cash Flow
-347.69-155.2-132.84-84.69-58.24
Upgrade
Unlevered Free Cash Flow
-347.69-155.01-132.84-84.68-58.19
Upgrade
Change in Net Working Capital
-2.55-70.191.45-11.291.51
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q